Hidradenitis suppurativa: A practical review of possible medical treatments based on over 350 hidradenitis patients

Dermatology Online Journal

Volumn 19, Issue 4, 2013, Pages

  Scheinfeld, Noah ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ANTIBIOTIC AGENT; CHLORHEXIDINE GLUCONATE; CLINDAMYCIN; CORTICOSTEROID; CYCLOSPORIN A; DAPSONE; DUTASTERIDE; ETANERCEPT; ETRETIN; FINASTERIDE; GENTAMICIN; GLUCONATE ZINC; IMMUNOGLOBULIN; INFLIXIMAB; ISONIAZID; ISOTRETINOIN; LYMECYCLINE; METFORMIN; METHOTREXATE; METRONIDAZOLE; MINOCYCLINE; ORAL CONTRACEPTIVE AGENT; PREDNISONE; RESORCINOL; RIFAMPICIN; SPIRONOLACTONE; TETRACYCLINE; TRIAMCINOLONE ACETONIDE; UNINDEXED DRUG; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; HORMONE; HORMONE ANTAGONIST; IMMUNOSUPPRESSIVE AGENT; RETINOID; SEX HORMONE; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL PAIN; ADD ON THERAPY; ANEMIA; ARTHRALGIA; ARTICLE; CARBON DIOXIDE LASER; CHEILITIS; CLOSTRIDIUM DIFFICILE INFECTION; COAGULASE NEGATIVE STAPHYLOCOCCUS; DEPRESSION; DERMATITIS; DIARRHEA; DISEASE CLASSIFICATION; DISEASE SEVERITY; DIZZINESS; DRESS SYNDROME; DRUG ANTAGONISM; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG FORMULATION; DRUG INDUCED HEADACHE; DRUG MECHANISM; DRUG WITHDRAWAL; ESOPHAGITIS; FATIGUE; GASTROINTESTINAL DISEASE; GASTROINTESTINAL SYMPTOM; HEMOLYSIS; HEPATITIS; HUMAN; HYPERKALEMIA; HYPERTRICHOSIS; INNATE IMMUNITY; LACTIC ACIDOSIS; LASER SURGERY; LIFESTYLE MODIFICATION; LOSS OF FUNCTION MUTATION; LUPUS LIKE SYNDROME; MALAISE; MULTIPLE SCLEROSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OTOTOXICITY; PATHOPHYSIOLOGY; PHASE 2 CLINICAL TRIAL (TOPIC); PHOTOSENSITIVITY; PIGMENT DISORDER; PSEUDOMEMBRANOUS COLITIS; PYOGENIC GRANULOMA; RANDOMIZED CONTROLLED TRIAL (TOPIC); RASH; RISK FACTOR; SIDE EFFECT; SKIN BURNING SENSATION; SKIN SURGERY; SQUAMOUS CELL CARCINOMA; STICKY SKIN; SUPPURATIVE HIDRADENITIS; TENDINITIS; TENDON RUPTURE; TESTOSTERONE BLOOD LEVEL; THORAX PAIN; THYROTROPIN BLOOD LEVEL; TINNITUS; UNSPECIFIED SIDE EFFECT; URINE COLOR; VAGINA CANDIDIASIS; VAGINA MYCOSIS; VERTIGO; WEIGHT REDUCTION; WOUND CARE; ABSCESS; ANALGESIA; ANTAGONISTS AND INHIBITORS; BANDAGE; BIOFILM; COMPLICATION; DRAINAGE; ESTHETIC SURGERY; HAIR FOLLICLE; HIDRADENITIS SUPPURATIVA; HYPERBARIC OXYGEN; MICROBIOLOGY; MULTIMODALITY CANCER THERAPY; OBESITY; PATHOLOGY; PHYSIOLOGY; STAPHYLOCOCCAL SKIN INFECTIONS; REVIEW; STAPHYLOCOCCAL SKIN INFECTION; WOUND DRAINAGE;

ABSCESS; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; BANDAGES; BIOFILMS; COMBINED MODALITY THERAPY; DRAINAGE; GONADAL STEROID HORMONES; HAIR FOLLICLE; HAIR REMOVAL; HIDRADENITIS SUPPURATIVA; HORMONE ANTAGONISTS; HORMONES; HUMANS; HYPERBARIC OXYGENATION; IMMUNOSUPPRESSIVE AGENTS; METFORMIN; OBESITY; PAIN MANAGEMENT; RETINOIDS; STAPHYLOCOCCAL SKIN INFECTIONS; TUMOR NECROSIS FACTOR-ALPHA; WEIGHT LOSS;

EID: 84876224770     PISSN: 10872108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (132)

1. Ingram JR, Wood M, John B, Butler R, Anstey AV. Absence of pathogenic γ-secretase mutations in a South Wales cohort of familial and sporadic hidradenitis suppurativa (acne inversa). Br J Dermatol. 2012 Sep 26. [PubMed]
2. Sartorius K, Killasli H, Oprica C, Sullivan A, Lapins J. Bacteriology of hidradenitis suppurativa exacerbations and deep tissue cultures obtained during carbon dioxide laser treatment. Br J Dermatol. 2012;166(4):879-883. [PubMed]
3. Lapins J, Jarstrand C, Emtestam L. Coagulase-negative staphylococci are the most common bacteria found in cultures from the deep portions of hidradenitis suppurativa lesions, as obtained by carbon dioxide laser surgery. Br J Dermatol. 1999;140:90-95. [PubMed]
4. Huebner J, Goldmann DA. Coagulase-negative staphylococci: role as pathogens. Annu Rev Med. 1999;50:223-236. [PubMed]
5. Piette A, Verschraegen G. Role of coagulase-negative staphylococci in human disease. Vet Microbiol. 2009;134(1/2):45-54. [PubMed]
6. Alhusayen R, Shear NH. Pharmacologic interventions for hidradenitis suppurativa: what does the evidence say? Am J Clin Dermatol. 2012;13:283-291. [PubMed]
7. Rambhatla PV, Lim HW, Hamzavi I.A systematic review of treatments for hidradenitis suppurativa. Arch Dermatol. 2012;148:439-446. [PubMed]
8. Mendonça CO, Griffiths CE. Clindamycin and rifampicin combination therapy for hidradenitis suppurativa. Br J Dermatol. 2006;154(5):977-978. [PubMed]
9. Gener G, Canoui-Poitrine F, Revuz JE, Faye O, Poli F, Gabison G, Pouget F, Viallette C, Wolkenstein P, Bastuji-Garin S Combination therapy with clindamycin and rifampicin for hidradenitis suppurativa: a series of 116 consecutive patients. Dermatology. 2009;219:148-154. [PubMed]
10. van der Zee HH, Boer J, Prens EP, Jemec GB. The effect of combined treatment with oral clindamycin and oral rifampicin in patients with hidradenitis suppurativa. Dermatology. 2009;219:143-147. [PubMed]
11. Join-Lambert O, Coignard H, Jais JP, Guet-Revillet H, Poirée S, Fraitag S, Jullien V, Ribadeau-Dumas F, Thèze J, Le Guern AS, Behillil S, Leflèche A, Berche P, Consigny PH, Lortholary O, Nassif X, Nassif A. Efficacy of rifampin-moxifloxacin-metronidazole combination therapy in hidradenitis suppurativa. Dermatology. 2011;222:49-58. [PubMed]
12. Aude Nassif, MD, Institut Pasteur, Paris, France; Helene Coignard, MD, Hospital Necker-Enfants Malades, Paris, France; Olivier Join-Lambert, MD, PhD, Faculte de Medecine Necker-Enfants Malades, Paris, France; Olivier Lortholary, MD, Faculte de Medecine Necker-Enfants Malades, Paris, France. Complete remission of severe hidradenitis suppurativa obtained in 4 patients using wide-spectrum antimicrobial treatment. J Am Acad Dermatol 2012 Apr 66(4) (Poster reference number 5181) AB46 (Abstract)
13. Revuz J. Antibiotic treatment of hidradenitis suppurativa. Ann Dermatol Venereol. 2012;139:532-541. [PubMed]
14. Hofer T, Itin PH. Acne inversa: a dapsone-sensitive dermatosis. Hautarzt. 2001;52(10 Pt 2):989-992. [PubMed]
15. Kaur MR, Lewis HM. Hidradenitis suppurativa treated with dapsone: A case series of five patients. J Dermatolog Treat. 2006;17(4):211-213. [PubMed]
16. Yazdanyar S, Boer J, Ingvarsson G, Szepietowski JC, Jemec GB. Dapsone therapy for hidradenitis suppurativa: a series of 24 patients. Dermatology. 2011;222:342-346. [PubMed]
17. Kozub P, Simaljakova M. Hidradenitis suppurativa treated with combination of infliximab and dapsone. Bratisl Lek Listy. 2012;113:319-323. [PubMed]
18. Clemmensen OJ. Topical treatment of hidradenitis suppurativa with clindamycin. Int J Dermatol. 1983;22:325-328. [PubMed]
19. Jemec GB, Wendelboe P. Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa. J Am Acad Dermatol. 1998;39:971-974. [PubMed]
20. Mahmoud BH, Tierney E, Hexsel CL, Pui J, Ozog DM, Hamzavi IH. Prospective controlled clinical and histopathologic study of hidradenitis suppurativa treated with the long-pulsed neodymium:yttrium-aluminium-garnet laser. J Am Acad Dermatol. 2010;62:637-645. [PubMed]
21. Boer J, Jemec GB Resorcinol peels as a possible self-treatment of painful nodules in hidradenitis suppurativa. Clin Exp Dermatol. 2010;35:36-40. [PubMed]
22. Weiner J, Lewis JE, Samitz MH. Hidradenitis suppurativa occurring on the leg. Cutis. 1976;17:888-891. [PubMed]
23. Boer J, van Gemert MJ. Long-term results of isotretinoin in the treatment of 68 patients with hidradenitis suppurativa. J Am Acad Dermatol. 1999;40:73-76. [PubMed]
24. Soria A, Canoui-Poitrine F, Wolkenstein P, Poli F, Gabison G, Pouget F, Viallette C, Revuz J. Absence of efficacy of oral isotretinoin in hidradenitis suppurativa: a retrospective study based on patients' outcome assessment. Dermatology. 2009;218:134-135. [PubMed]
25. Norris JF, Cunliffe WJ. Failure of treatment of familial widespread hidradenitis suppurativa with isotretinoin. Clin Exp Dermatol. 1986;11:579-583. [PubMed]
26. Kamp S, Fiehn AM, Stenderup K, Rosada C, Pakkenberg B, Kemp K, Dam TN, Jemec GB. Hidradenitis suppurativa: a disease of the absent sebaceous gland? Sebaceous gland number and volume are significantly reduced in uninvolved hair follicles from patients with hidradenitis suppurativa. Br J Dermatol. 2011;164:1017-1022. [PubMed]
27. Scheman AJ. Nodulocystic acne and hidradenitis suppurativa treated with acitretin: a case report. Cutis. 2002;69:287-288. [PubMed]
28. Hogan DJ, Light MJ. Successful treatment of hidradenitis suppurativa with acitretin. J Am Acad Dermatol. 1988;19(2 Pt 1):355-356. [PubMed]
29. Boer J, Nazary M. Long-term results of acitretin therapy for hidradenitis suppurativa: is acne inversa also a misnomer? Br J Dermatol. 2011;164:170-175. [PubMed]
30. Puri N, Talwar A. A study on the management of hidradenitis suppurativa with retinoids and surgical excision. Indian J Dermatol. 2011;56:650-651. [PubMed]
31. Camisa C, Sexton C, Friedman C. Treatment of hidradenitis suppurativa with combination hypothalamic-pituitary-ovarian and adrenal suppression. A case report. J Reprod Med. 1989 Aug;34(8):543-546. J Reprod Med. 1989;34:543-6.
32. Goldsmith PC, Dowd PM. Successful therapy of the follicular occlusion triad in a young woman with high dose oral antiandrogens and minocycline. J R Soc Med. 1993;86:729-730. [PubMed]
33. Mortimer PS, Dawber RP, Gales MA, Moore RA. A double-blind controlled cross-over trial of cyproterone acetate in females with hidradenitis suppurativa. Br J Dermatol 1986;115:263-268. [PubMed]
34. Kraft JN, Searles GE. Hidradenitis suppurativa in 64 female patients: retrospective study comparing oral antibiotics and antiandrogen therapy. J Cutan Med Surg 2007;11:125-131. [PubMed]
35. Joseph MA, Jayaseelan E, Ganapathi B, Stephen J. Hidradenitis suppurativa treated with finasteride. J Dermatolog Treat. 2005;16:75-78. [PubMed]
36. Farrell AM, Randall VA, Vafaee T, Dawber RP. Finasteride as a therapy for hidradenitis suppurativa. Br J Dermatol. 1999; 141:1138-1139. [PubMed]
37. Doménech C, Matarredona J, Escribano-Stablé JC, Devesa JP, Vicente J, Jaén A. Facial hidradenitis suppurativa in a 28-year-old male responding to finasteride. Dermatology. 2012;224:307-308. [PubMed]
38. Brocard A, Knol AC, Khammari A, Dréno B. Hidradenitis suppurativa and zinc: a new therapeutic approach. A pilot study. Dermatology. 2007;214:325-327. [PubMed]
39. Verdolini R, Clayton N, Smith A, Alwash N, Mannello B. Metformin for the treatment of hidradenitis suppurativa: a little help along the way. J Eur Acad Dermatol Venereol. 2012 Aug 11. [PubMed]
40. Arun B, Loffeld A. Long-standing hidradenitis suppurativa treated effectively with metformin. Clin Exp Dermatol. 2009;34:920-921. [PubMed]
41. Rose RF, Goodfield MJ, Clark SM. Treatment of recalcitrant hidradenitis suppurativa with oral ciclosporin. Clin Exp Dermatol. 2006;31:154-155. [PubMed]
42. Buckley DA, Rogers S. Cyclosporin-responsive hidradenitis suppurativa. J R Soc Med. 1995;88:289-290. [PubMed]
43. Gupta AK, Ellis CN, Nickoloff BJ, Goldfarb MT, Ho VC, Rocher LL, Griffiths CE, Cooper KD, Voorhees JJ. Oral ciclosporin in the treatment of inflammatory and noninflammatory dermatoses: a clinical and immunopathologic analysis. Arch Dermatol 1990;126:339-350. [PubMed]
44. Marquardt AL, Hackshaw KV. Reactive arthritis associated with hidradenitis suppurativa. J Natl Med Assoc. 2009;101:367-369. [PubMed]
45. Arthritis associated with hidradenitis suppurativa. Bhalla R, Sequeira W. Ann Rheum Dis. 1994;53:64-66. [PubMed]
46. Fearfield LA, Staughton RC. Severe vulval apocrine acne successfully treated with prednisolone and isotretinoin. Clin Exp Dermatol. 1999;24:189-192. [PubMed]
47. De Souza A, Solomon GE, Strober BE. SAPHO syndrome associated with hidradenitis suppurativa successfully treated with infliximab and methotrexate. Bull NYU Hosp Jt Dis. 2011;69:185-187. [PubMed]
48. Jemec GB. Methotrexate is of limited value in the treatment of hidradenitis suppurativa. Clin Exp Dermatol. 2002;27:528-529. [PubMed]
49. Reddick CL, Singh MN, Chalmers RJ. Successful treatment of superficial pyoderma gangrenosum associated with hidradenitis suppurativa with adalimumab. Dermatol Online J. 2010;16(8):15. [PubMed]
50. The anti-inflammatory drug colchicine lacks efficacy in hidradenitis suppurativa. van der Zee HH, Prens EP. Dermatology. 2011;223:169-173. [PubMed]
51. Miller IM, Dufour DN, Jemec GB. Treatment of hidradenitis suppurativa: is oral isoniazid an option? J Dermatolog Treat. 2012;23:128-130. [PubMed]
52. Lee RA, Dommasch E, Treat J, Sciacca-Kirby J, Chachkin S, Williams J, Shin DB, Leyden JJ, Vittorio C, Gelfand JM. A prospective clinical trial of open-label etanercept for the treatment of hidradenitis suppurativa. J Am Acad Dermatol. 2009;60:565-573. [PubMed]
53. Strober BE, Kim C, Siu K. Efalizumab for the treatment of refractory hidradenitis suppurativa. J Am Acad Dermatol. 2007;57:1090-1091. [PubMed]
54. Goo B, Chung HJ, Chung WG, Chung KY. Intramuscular immunoglobulin for recalcitrant suppurative diseases of the skin: a retrospective review of 63 cases. Br J Dermatol. 2007;157:563-568. [PubMed]
55. Dréno B, Khammari A, Brocard A, Moyse D, Blouin E, Guillet G, Léonard F, Knol AC. Hidradenitis suppurativa: the role of deficient cutaneous innate immunity. Arch Dermatol. 2012;148:182-186. [PubMed]
56. van der Zee HH, de Ruiter L, van den Broecke DG, Dik WA, Laman JD, Prens EP. Elevated levels of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-α and IL-1β. Br J Dermatol. 2001;164:1292-1298. [PubMed]
57. Schlapbach C, Hänni T, Yawalkar N, Hunger RE. Expression of the IL-23/Th17 pathway in lesions of hidradenitis suppurativa. J Am Acad Dermatol. 2011;65:790-798. [PubMed]
58. Scheinfeld N. Treatment of coincident seronegative arthritis and hidradentis supprativa with adalimumab. J Am Acad Dermatol. 2006;55:163-164. [PubMed]
59. Blanco R, Martínez-Taboada VM, Villa I, et al. Long-term successful adalimumab therapy in severe hidradenitis suppurativa. Arch Dermatol. 2009;145:580-584. [PubMed]
60. Amano M, Grant A, Kerdel FA. A prospective open-label clinical trial of adalimumab for the treatment of hidradenitis suppurativa. Int J Dermatol. 2010;49:950-955. [PubMed]
61. Miller I, Lynggaard CD, Lophaven S, Zachariae C, Dufour DN, Jemec GB. A double-blind placebo-controlled randomized trial of adalimumab in the treatment of hidradenitis suppurativa. Br J Dermatol. 2011;165:391-398. [PubMed]
62. Arenbergerova M, Gkalpakiotis S, Arenberger P. Effective long-term control of refractory hidradenitis suppurativa with adalimumab after failure of conventional therapy. Int J Dermatol. 2010;49:1445-1449. [PubMed]
63. Paradela S, Rodríguez-Lojo R, Fernández-Torres R, Arévalo P, Fonseca E. Long-term efficacy of infliximab in hidradenitis suppurativa. J Dermatolog Treat. 2012;23:278-283. [PubMed]
64. Grant A, Gonzalez T, Montgomery MO, Cardenas V, Kerdel FA. Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: a randomized, double-blind, placebo-controlled crossover trial. J Am Acad Dermatol. 2010;62:205-217. [PubMed]
65. van Rappard DC, Leenarts MF, Meijerink-van't Oost L, Mekkes JR. Comparing treatment outcome of infliximab and adalimumab in patients with severe hidradenitis suppurativa. J Dermatolog Treat. 2012;23:284-289. [PubMed]
66. Gulliver WP, Jemec GB, Baker KA. Experience with ustekinumab for the treatment of moderate to severe Hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2012;26:911-914. [PubMed]
67. Sharon VR, Garcia MS, Bagheri S, Goodarzi H, Yang C, Ono Y, Maverakis E. Management of recalcitrant hidradenitis suppurativa with ustekinumab. Acta Derm Venereol. 2012;92:320-321. [PubMed]
68. Mortimore M, Florin TH. A role for B12 in inflammatory bowel disease patients with suppurative dermatoses? An experience with high dose vitamin B12 therapy. J Crohns Colitis. 2010;4:466-470. [PubMed]
69. Cusack C, Buckley C. Etanercept: effective in the management of hidradenitis suppurativa. Br J Dermatol. 2006;154:726-729. [PubMed]
70. Braun-Falco M, Kovnerystyy O, Lohse P, Ruzicka T. Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH)--a new autoinflammatory syndrome distinct from PAPA syndrome. J Am Acad Dermatol. 2012;66:409-415. [PubMed]
71. Red papules and Nodules Lynch PJ, Edwards L. in Genital Dermatology. pp 101-115. Churchill Livingstone. New York 1994.
72. Coleman, WP Hidradenitis Suppurativa pp 481-484. in Cutaneous Medicine and Surgery. Arndt KA, LeBoit PE, Robinson JK, Wintroub BU. WB Saunders Company. Philadelphia 1996.
73. Kathju S, Lasko LA, Stoodley P. Considering hidradenitis suppurativa as a bacterial biofilm disease. FEMS Immunol Med Microbiol. 2012;65:385-389. [PubMed]
74. Messikh R, Atallah L, Aubin F, Humbert P. Botulinum toxin in disabling dermatological diseases. Ann Dermatol Venereol. 2009;136 Suppl 4:S129-S136. [PubMed]
75. Feito-Rodríguez M, Sendagorta-Cudós E, Herranz-Pinto P, de Lucas-Laguna R. Prepubertal hidradenitis suppurativa successfully treated with botulinum toxin A. Dermatol Surg. 2009;35:1300-1302. [PubMed]
76. O'Reilly DJ, Pleat JM, Richards AM. Treatment of hidradenitis suppurativa with botulinum toxin A. Plast Reconstr Surg. 2005;116:1575-1576. [PubMed]
77. Sinclair R, Wewerinke M, Jolley D. Treatment of female pattern hair loss with oral antiandrogens. Br J Dermatol. 2005;152:466-473. [PubMed]
78. Kelekci KH, Kelekci S, Yengel I, Gul S, Yilmaz B. Cyproterone acetate or drospirenone containing combined oral contraceptives plus spironolactone or cyproterone acetate for hirsutism: randomized comparison of three regimens. J Dermatolog Treat. 2012;23:177-183. [PubMed]
79. Vazquez BG, Alikhan A, Weaver AL, Wetter DA, Davis MD. Incidence of hidradenitis suppurativa and associated factors: a population-based study of Olmsted County, Minnesota. J Invest Dermatol. 2013;133:97-103. [PubMed]
80. Mebazaa A, Ben Hadid R, Cheikh Rouhou R, Trojjet S, El Euch D, Mokni M, Zitouna M, Ben Osman A. Hidradenitis suppurativa: a disease with male predominance in Tunisia. Acta Dermatovenerol Alp Panonica Adriat. 2009;18:165-172. [PubMed]
81. Jemec GB. Clinical practice. Hidradenitis suppurativa. N Engl J Med. 2012 12;366:158-164. [PubMed]
82. Kimball AB, Kerdel F, Adams D, Mrowietz U, Gelfand JM, Gniadecki R, Prens EP, Schlessinger J, Zouboulis CC, van der Zee HH, Rosenfeld M, Mulani P, Gu Y, Paulson S, Okun M, Jemec GB. Adalimumab for the treatment of moderate to severe Hidradenitis suppurativa: a parallel randomized trial. Ann Intern Med. 2012;157:846-855. [PubMed]
83. Ozdemir Y, Uzun G, Mutluoglu M, Gulec B. Hyperbaric oxygen therapy for the management of postsurgical wounds in hidradenitis suppurativa. Am Surg. 2010;76(12):E237-E238. [PubMed]
84. Uzun G, Ozdemir Y, Mutluoǧlu M, Güleç B. Hyperbaric oxygen therapy as an adjunct to surgical treatment of extensive hidradenitis suppurativa. World J Surg. 2010;34:861-862. [PubMed]
85. Sharon-Guidetti A, Ziv Y, Kummer E, Yogev R, Halevy A. Granulocyte-macrophage colony-stimulating factor for perianal hidradenitis suppurativa: report of a case. Dis Colon Rectum. 2006;49:682-684. [PubMed]
86. Wang B, Yang W, Wen W, Sun J, Su B, Liu B, Ma D, Lv D, Wen Y, Qu T, Chen M, Sun M, Shen Y, Zhang X. Gamma-secretase gene mutations in familial acne inversa. Science. 2010;330(6007):1065. [PubMed]
87. Scheinfeld N. Hidradenitis should not be renamed acne inversa. Dermatol Online J. 2006;12(7):6. [PubMed]
88. Sellheyer K, Krahl D.Hidradenitis suppurativa is acne inversa! An appeal to (finally) abandon a misnomer. Int J Dermatol. 2005;4:535-40. [PubMed]
89. Wolkenstein P, Loundou A, Barrau K, Auquier P, Revuz J; Quality of Life Group of the French Society of Dermatology Quality of life impairment in hidradenitis suppurativa: a study of 61 cases. J Am Acad Dermatol. 2007;56:621-623. [PubMed]
90. Lassila R, Lepäntalo M. Cigarette smoking and the outcome after lower limb arterial surgery. Acta Chir Scand. 1988;154:635-640. [PubMed]
91. Evers T, Doll D, Matevossian E, Noe S, Neumann K, Li HL, Hüser N, Lüdde R, Hoffmann S, Krapohl BD. Trends in incidence and long-term recurrence rate of pilonidal sinus disease and analysis of associated influencing factors. Zhonghua Wai Ke Za Zhi. 2011;49:799-803. [PubMed]
92. Sabat R, Chanwangpong A, Schneider-Burrus S, Metternich D, Kokolakis G, Kurek A, Philipp S, Uribe D, Wolk K, Sterry W. Increased prevalence of metabolic syndrome in patients with acne inversa. PLoS One. 2012;7:e31810. [PubMed]
93. Canoui-Poitrine F, Le Thuaut A, Revuz JE, Viallette C, Gabison G, Poli F, Pouget F, Wolkenstein P, Bastuji-Garin S. Identification of Three Hidradenitis Suppurativa Phenotypes: Latent Class Analysis of a Cross-Sectional Study. J Invest Dermatol. 2012 Dec 13. [PubMed]
94. van der Zee HH, Prens EP, Boer J. Deroofing: a tissue-saving surgical technique for the treatment of mild to moderate hidradenitis suppurativa lesions. J Am Acad Dermatol. 2010;63:475-480. [PubMed]
95. Mortimer PS, Dawber RP, Gales MA, Moore RA. Mediation of hidradenitis suppurativa by androgens. Br Med J (Clin Res Ed). 1986;292:245-248. [PubMed]
96. Thomsen SF, Sørensen LT. Smoking and skin disease. Skin Therapy Lett. 2001;1:4-7. [PubMed]
97. Girouard SD, Falk RH, Rennke HG, Merola JF. Hidradenitis suppurativa resulting in systemic amyloid A amyloidosis: a case report and review of the literature. Dermatol Online J. 2012;18(1):2. [PubMed]
98. Ah-Weng A, Langtry JA, Velangi S, Evans CD, Douglas WS. Pyoderma gangrenosum associated with hidradenitis suppurativa. Clin Exp Dermatol. 2005;30:669-671. [PubMed]
99. Tennant F Jr, Bergeron JR, Stone OJ, Mullins JF. Anemia associated with hidradenitis suppurativa. Arch Dermatol. 1968;98:138-140. [PubMed]
100. Moschella SL. Hidradenitis suppurativa. Complications resulting in death. JAMA. 1966;198(1):201-203. [PubMed]
101. Melnik BC, Plewig G. Impaired Notch signalling: the unifying mechanism explaining the pathogenesis of hidradenitis suppurativa (acne inversa). Br J Dermatol. 2012 Sep 28. [PubMed]
102. Anstey AV. γ-Secretase gene mutations link acne inversa with Alzheimer's disease. Br J Dermatol. 2011;164(2):235-236. [PubMed]
103. Kelleher RJ 3rd, Shen J. Genetics. Gamma-secretase and human disease. Science. 2010;330(6007): [PubMed]
104. Highet AS, Warren RE, Staughton RC, Roberts SO. Streptococcus milleri causing treatable infection in perineal hidradenitis suppurativa. Br J Dermatol. 1980;103:375-382. [PubMed]
105. Jemec GB, Faber M, Gutschik E, Wendelboe P. The bacteriology of hidradenitis suppurativa. Dermatology. 1996;193:203-206.
106. Highet AS, Warren RE, Weekes AJ. Bacteriology and antibiotic treatment of perineal suppurative hidradenitis. Arch Dermatol. 1988;124:1047-1051. [PubMed]
107. Ringpfeil F. Selected disorders of connective tissue: pseudoxanthoma elasticum, cutis laxa, and lipoid proteinosis. Clin Dermatol. 2005;23:41-46. [PubMed]
108. Arnadottir M, Jonsson E, Jonsson J. Inactivity of hidradenitis suppurativa after renal transplantation. Transplantation. 2006; 82:849. [PubMed]
109. Caliskan Y, Yazici H, Kucuk M, Alisir S, Kilicaslan I, Ecder T. Nephrotic syndrome associated with hidradenitis suppurativa. Clin Nephrol. 2005;63:171-172. [PubMed]
110. Buimer MG, Ankersmit MF, Wobbes T, Klinkenbijl JH. Surgical treatment of hidradenitis suppurativa with gentamicin sulfate: a prospective randomized study. Dermatol Surg. 2008; 34:224-227. [PubMed]
111. Wilkinson JD. Fusidic acid in dermatology. Br J Dermatol. 1998;139 Suppl 53:37-40. [PubMed]
112. Gül HC, Coşkun O, Savaşci U, Ors F, Beşirbellioǧlu AB, Eyigün CP. A case of meningitis emerged as a complication of hidradenitis suppurativa. Mikrobiyol Bul. 2009 Jan;43(1):153-157. [PubMed]
113. Chow ET, Mortimer PS. Successful treatment of hidradenitis suppurativa and retroauricular acne with etretinate. Br J Dermatol. 1992;126:415. [PubMed]
114. Barth JH, Layton AM, Cunliffe WJ. Endocrine factors in pre- and postmenopausal women with hidradenitis suppurativa. Br J Dermatol. 1996;134:1057-1059. [PubMed]
115. Farrell AM, Dawber RP. Endocrine factors in pre- and postmenopausal women with hidradenitis suppurativa. Br J Dermatol. 1997;136:802-803. [PubMed]
116. Bogers JW, Minderhoud-Bassie W, Huikeshoven FJ. A case of hidradenitis suppurativa treated with gonadotropin-releasing hormone agonist and by total abdominal hysterectomy with bilateral salpingo-oophorectomy. Am J Obstet Gynecol. 1992;167:517-518. [PubMed]
117. Morgan WP, Leicester G. The role of depilation and deodorants in hidradenitis suppurativa. Arch Dermatol. 1982;118:101-102. [PubMed]
118. Edlich RF, Silloway KA, Rodeheaver GT, Cooper PH. Epidemiology, pathology, and treatment of axillary hidradenitis suppurativa. J Emerg Med. 1986;4:369-378. [PubMed]
119. von Laffert M, Stadie V, Wohlrab J, Marsch WC. Hidradenitis suppurativa/acne inversa: bilocated epithelial hyperplasia with very different sequelae. Br J Dermatol. 2011;164:367-371. [PubMed]
120. William Danby F, Jemec GB, Marsch WC, von Laffert M. Preliminary findings suggest hidradenitis suppurativa may be due to defective follicular support. Br J Dermatol. 2013 Jan 16. [PubMed]
121. Wieland CW, Vogl T, Ordelman A, Vloedgraven HG, Verwoolde LH, Rensen JM, Roth J, Boer J, Hessels J. Myeloid marker S100A8/A9 and lymphocytemarker soluble interleukin 2 receptor: Biomarkers of hidradenitis suppurativa disease activity? Br J Dermatol. 2013 Jan 16. [PubMed]
122. Matusiak L, Bieniek A, Szepietowski JC. Soluble interleukin-2 receptor serum level is a useful marker of hidradenitis suppurativa clinical staging. Biomarkers. 2009;14:432-437. [PubMed]
123. Ma L, Dominguez AR, Collins GR, Kia KF, Cockerell CJ. Hidradenitis Suppurativa, Eruptive Melanocytic Nevi, and Keratosis Pilaris-like Eruption in a Patient Treated With Vemurafenib. Arch Dermatol. 2012;148:1428-1429. [PubMed]
124. Marinella MA. Lithium therapy associated with hidradenitis suppurativa. Acta Derm Venereol. 1997;77:483. [PubMed]
125. Gupta AK, Knowles SR, Gupta MA, Jaunkalns R, Shear NH. Lithium therapy associated with hidradenitis suppurativa: case report and a review of the dermatologic side effects of lithium. J Am Acad Dermatol. 1995;32(2 Pt 2):382-386. [PubMed]
126. Moroz A, Lee MH, Clark J. Reflex sympathetic dystrophy with hidradenitis suppurativa exacerbation: a case report. Arch Phys Med Rehabil. 2001;82:412-414. [PubMed]
127. Sartorius K, Emtestam L, Lapins J, Johansson O. Cutaneous PGP 9.5 distribution patterns in hidradenitis suppurativa. Arch Dermatol Res. 2010;302:461-468. [PubMed]
128. P6570 Alitretinoin in the treatment of hidradenitis suppurativa: An insight. Samuel Menon, MBBS, Princess Alexandra Hospital, Essex, United Kingdom; Roberto Verdolini, MD, Princess Alexandra Hospital, Essex, United Kingdom. Journal of the American Academy of Dermatology Vol. 68, Issue 4, Supplement 1, Page AB8 (Abstract)
129. Gill JF, Yu SS, Neuhaus IM. Tobacco smoking and dermatologic surgery. J Am Acad Dermatol. 2013;68:167-172. [PubMed]
130. Lasocki A, Sinclair R, Foley P, Saunders H. Hidradenitis suppurativa responding to treatment with infliximab. Australas J Dermatol. 2001;51:186-190. [PubMed]
131. Yazdanyar S, Miller IM, Jemec GB. Hidradenitis suppurativa and Crohn's disease: two cases that support an association. Acta Dermatovenerol Alp Panonica Adriat. 2010;19:23-25. [PubMed]
132. dos Santos CH, Netto PO, Kawaguchi KY, Parreira Alves JA, de Alencar Souza VP, Reverdito S. Association and management of Crohn's disease plus hidradenitis suppurativa. Inflamm Bowel Dis. 2012;18(4):E801-E802. [PubMed]